Next Article in Journal
Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
Previous Article in Journal
Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
 
 
Review

Article Versions Notes

Curr. Oncol. 2021, 28(2), 1412-1423; https://doi.org/10.3390/curroncol28020134
Action Date Notes Link
article pdf uploaded. 6 April 2021 14:32 CEST Version of Record https://www.mdpi.com/1718-7729/28/2/134/pdf-vor
article xml file uploaded 8 April 2021 10:04 CEST Original file -
article xml uploaded. 8 April 2021 10:04 CEST Update https://www.mdpi.com/1718-7729/28/2/134/xml
article pdf uploaded. 8 April 2021 10:04 CEST Updated version of record https://www.mdpi.com/1718-7729/28/2/134/pdf
article html file updated 8 April 2021 10:09 CEST Original file -
article html file updated 9 April 2021 10:00 CEST Update -
article html file updated 4 August 2021 10:47 CEST Update -
article html file updated 25 July 2022 10:58 CEST Update https://www.mdpi.com/1718-7729/28/2/134/html
Back to TopTop